These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 5469211

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Clinical-pharmacological studies on the effect of an extract from Ginkgo biloba L. in the postthrombotic syndrome].
    Tronnier H.
    Arzneimittelforschung; 1968 May; 18(5):551-4. PubMed ID: 5755882
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The cardiovascular pharmacology of lidoflazine, a long-acting coronary vasodilator.
    Schaper WK, Xhoneux R, Jageneau AH, Janssen PA.
    J Pharmacol Exp Ther; 1966 May; 152(2):265-74. PubMed ID: 5944369
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Histamine and circulatory homeostasis.
    Schayer RW.
    Fed Proc; 1965 May; 24(6):1295-7. PubMed ID: 5853523
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Trials concerning the mechanism of action of Myocalme therapy in arterial circulatory disorders of the extremities].
    Foldi M, Zoltan OT, Jancso T, Lakos A, Antal A, Sagi I.
    Angeiologie; 1965 May; 17(3):27-31. PubMed ID: 5832679
    [No Abstract] [Full Text] [Related]

  • 13. [Effect of Intensain, a coronary dilator, on hemodynamics and its application for general anesthesia].
    Saito T, Okazaki K, Hirano T, Matsuzaki T, Wakizaka K.
    Masui; 1966 Mar; 15(3):251-7. PubMed ID: 6007412
    [No Abstract] [Full Text] [Related]

  • 14. [The influence of Hexobendin on the coronary arteriovenous O2 difference in humans].
    Hilger HH, Schaede A, Wagner J, Louven B, Wackerbauer J, Hellwig H.
    Z Kreislaufforsch; 1967 Feb; 56(2):164-79. PubMed ID: 5592238
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A peptide fraction from lung tissue with prolonged peripheral vasodilator activity.
    Said SI, Mutt V.
    Scand J Clin Lab Invest Suppl; 1969 Feb; 107():51-6. PubMed ID: 5375727
    [No Abstract] [Full Text] [Related]

  • 17. [Angiographic study of a new vasodilator agent].
    Pinet F, Rubet A.
    Therapeutique; 1973 Nov; 49(9):601-3. PubMed ID: 4600039
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Potentiation of reactive hyperemia in the coronary and femoral circulation by the selective use of 2,6-bis(diethanolamino)-4,8-dipiperidino-pyrimodo[5,4-d]pyrimidine.
    Miura M, Tominaga S, Hashimoto K.
    Arzneimittelforschung; 1967 Aug; 17(8):976-9. PubMed ID: 5632072
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.